Novo Nordisk paid clinicians at least $25.8 million over a decade in fees and expenses related to its weight-loss drugs, concentrating that money on an elite group of obesity specialists.
In a social media landscape shaped by hashtags, algorithms, and viral posts, nurse leaders must decide: Will they let the narrative spiral, or can they adapt and join the conversation?
...
